Skip to main content
. 2020 Jan 30;109(9):1107–1113. doi: 10.1007/s00392-020-01602-3

Table 1.

Values are mean ± standard deviation, n (%) or median (interquartile range)

TTS (n = 13) Controls (n = 13)
Age, years 71.3 ± 6.2 65.6 ± 7.7
Systolic blood pressure, mmHg 124 ± 29 144 ± 14
Heart rate, beats/min 84.5 ± 15.7 67.5 ± 7.6
Body mass index 24.5 ± 3.2 24.8 ± 2.8
Serum creatinine, mg/dl 0.81 ± 0.16 0.96 ± 0.31
Clinical features of heart failure/myocardial damage
 Left ventricular ejection fraction, % 51.0 ± 12.8 58.4 ± 4.6
 N-terminal pro-B-type natriuretic peptide, ng/l 3066 ± 3737 161 ± 142
 Creatine kinase, U/l 239 ± 164 85 ± 36
 Troponin T, ng/l 646.9 ± 503.5 6.5 ± 2.9
Medical history
 Arterial hypertension 8 (61.5) 8 (61.5)
 Diabetes mellitus 1 (7.7) 0 (0)
 Hyperlipidemia 8 (61.5) 7 (53.8)
 Chronic obstructive pulmonary disease 1 (7.7) 0 (0)
 Peripheral artery disease 1 (7.7) 0 (0)